Tower Research Capital (TRC)’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,130
| Closed | -$4.63K | – | 5467 |
|
|
2025
Q1 | $4.63K | Buy |
+1,130
| New | +$4.63K | ﹤0.01% | 4227 |
|
|
2024
Q4 | – | Sell |
-466
| Closed | -$3.28K | – | 5898 |
|
|
2024
Q3 | $3.28K | Buy |
466
+447
| +2,353% | +$3.15K | ﹤0.01% | 4873 |
|
|
2024
Q2 | $3.3K | Buy |
19
+14
| +280% | +$2.43K | ﹤0.01% | 4906 |
|
|
2024
Q1 | $5.02K | Buy |
5
+3
| +150% | +$3.01K | ﹤0.01% | 4595 |
|
|
2023
Q4 | $6.32K | Sell |
2
-2
| -50% | -$6.32K | ﹤0.01% | 4757 |
|
|
2023
Q3 | $8.24K | Buy |
4
+3
| +300% | +$6.18K | ﹤0.01% | 4371 |
|
|
2023
Q2 | $3.49K | Buy |
+1
| New | +$3.49K | ﹤0.01% | 5042 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6123 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$8K | – | 6197 |
|
|
2022
Q3 | $8K | Hold |
1
| – | – | ﹤0.01% | 4796 |
|
|
2022
Q2 | $9K | Hold |
1
| – | – | ﹤0.01% | 4574 |
|
|
2022
Q1 | $8K | Buy |
+1
| New | +$8K | ﹤0.01% | 4598 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6415 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6025 |
|